Bear Stearns Cuts Genzyme to Peer Perform

Cites Medicare's plans to dramatically cut reimbursement for the company's product Synvisc in 2006

Bear Stearns cut Genzyme (GENZ ) to peer perform from outperform, citing Medicare's plans to dramatically cut reimbursement for the company's product Synvisc in 2006.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.